Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Biological therapies such as beta alethine use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I/II trial to study the effectiveness of beta alethine in treating patients who have Waldenstrom's macroglobulinemia.

Key facts

Study ID

NCT00041379

Run by

LifeTime Pharmaceuticals

Starts

2002-03-01

Last updated by the study team

2013-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Victory Over Cancer — Rockville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.